Breaking News Instant updates and real-time market news.

XERS

Xeris Pharmaceuticals

$5.18 /

-0.12 (-2.26%)

08:09
06/18/20
06/18
08:09
06/18/20
08:09

Xeris Pharmaceuticals announces topline results from XP-3924 study

Xeris Pharmaceuticals announced topline results from a proof-of-concept Phase 2 study of a novel Xerisol pramlintide-insulin co-formulation, or XP-3924, in adults with type 1 diabetes mellitus. XP-3924 is designed to improve the synergistic combination of two therapies: pramlintide and insulin. The separate administration of these existing therapies in combination reduces both post-prandial glucose excursions and glucose variability, as well as improves overall glycemic control. A pramlintide-insulin co-formulation may help reduce the daily burden associated with pramlintide co-administration. This reduction in the multiple injection burden using XP-3924 may also improve longer term pramlintide treatment adherence and persistency. The completed Phase 2 study was a randomized, open-label, active comparator-controlled, three-period cross-over study, which enrolled 18 adult participants with type 1 diabetes. This study aimed to investigate the pharmacokinetics, pharmacodynamics, and the safety and tolerability of a single dose of XP-3924. Subjects were randomly allocated to a sequence of three treatments: XP-3924, regular insulin, or regular insulin plus pramlintide co-administered as separate injections. The study drugs were administered subcutaneously before the intake of a standardized 75-gram oral glucose challenge. The subjects' blood glucose levels were monitored for 6 hours after drug dosing. Treatment with XP-3924 resulted in a 62.3% reduction of hyperglycemia after the glucose challenge when compared to Humulin. Additionally, XP-3924 exhibited comparable postprandial glycemic control to that of the co-administered injections of Humulin and Symlin. The mean absolute change in blood glucose was less in XP-3924 when compared to both Humulin and co-administered injections of Humulin and Symlin after the oral glucose challenge. The glucose variability after treatment with XP-3924 was less than both Humulin and co-administered injections of Humulin and Symlin, as defined by the comparison of the coefficient of variation of all plasma glucose readings across the sjx-hour duration of study treatments. The incidence and severity of treatment emergent adverse events was comparable across all treatment arms, as were the overall number of hypoglycemic events during dosing visits. There were minimal gastrointestinal side-effects reported in any treatment arm. There was a comparable incidence of injection site reactions and no edema was noted, across all treatment arms. XP-3924 was safe and well tolerated, and no serious adverse events occurred in this study.

XERS Xeris Pharmaceuticals
$5.18 /

-0.12 (-2.26%)

04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
02/18/20 Piper Sandler
Xeris Pharmaceuticals initiated with an Overweight at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
Stanley Black & Decker raises quarterly dividend by 1.4% to 70c per share » 17:11
07/14/20
07/14
17:11
07/14/20
17:11
SWK

Stanley Black & Decker

$146.38 /

+4.27 (+3.00%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

07:43 Today Deutsche Bank
Stanley Black & Decker named short-term buy idea at Deutsche Bank
07/10/20 JPMorgan
Stanley Black & Decker price target raised to $175 from $130 at JPMorgan
06/25/20 Wolfe Research
Stanley Black & Decker upgraded to Outperform from Peer Perform at Wolfe Research
06/16/20 Barclays
Stanley Black & Decker price target raised to $150 from $130 at Barclays
SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

SWK Stanley Black & Decker
$146.38 /

+4.27 (+3.00%)

Periodicals
Moderna COVID-19 vaccine data shows immune response, STAT says » 17:07
07/14/20
07/14
17:07
07/14/20
17:07
MRNA

Moderna

$75.04 /

+3.32 (+4.63%)

According to data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$75.04 /

+3.32 (+4.63%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

10:56 Today Piper Sandler
Moderna COVID vaccine trial on track for July start, says Piper Sandler
07/13/20 Brookline
Moderna initiated with a Buy at Brookline
07/13/20 Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
MRNA Moderna
$75.04 /

+3.32 (+4.63%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$75.04 /

+3.32 (+4.63%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

Hot Stocks
Carrier Global introduces Carrier Alliance to optimize supply chain » 17:04
07/14/20
07/14
17:04
07/14/20
17:04
CARR

Carrier Global

$25.16 /

+0.89 (+3.67%)

Carrier Global introduced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

06/22/20 UBS
Carrier Global initiated with a Buy at UBS
06/16/20 Argus
Carrier Global initiated with a Buy at Argus
06/15/20 Barclays
Carrier Global price target raised to $26 from $22 at Barclays
06/10/20 JPMorgan
JPMorgan's Tusa downgrades Carrier Global, removes from Focus List
CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

CARR Carrier Global
$25.16 /

+0.89 (+3.67%)

Syndicate
iMedia Brands files $100M mixed securities shelf  17:03
07/14/20
07/14
17:03
07/14/20
17:03
IMBI

iMedia Brands

$3.41 /

+0.18 (+5.57%)

 
ShowHide Related Items >><<
IMBI iMedia Brands
$3.41 /

+0.18 (+5.57%)

IMBI iMedia Brands
$3.41 /

+0.18 (+5.57%)

05/28/20 Lake Street
iMedia Brands price target raised to $5 from $3 at Lake Street
04/21/20 Lake Street
iMedia Brands price target lowered to $3 from $15 at Lake Street
04/16/20 DA Davidson
iMedia Brands price target lowered to $4 from $10 at DA Davidson
12/20/19 DA Davidson
iMedia Brands initiated with a Buy at DA Davidson
IMBI iMedia Brands
$3.41 /

+0.18 (+5.57%)

Hot Stocks
PVH Corp. to reduce office workforce by 450 positions, take $80M charge » 17:02
07/14/20
07/14
17:02
07/14/20
17:02
PVH

PVH Corp.

$46.52 /

+1.14 (+2.51%)

PVH Corp "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

06/15/20 DA Davidson
PVH Corp. price target raised to $60 from $41 at DA Davidson
06/15/20 Barclays
PVH Corp. price target lowered to $51 from $67 at Barclays
06/15/20 RBC Capital
PVH Corp. price target raised to $48 from $30 at RBC Capital
06/12/20 Deutsche Bank
PVH Corp. price target lowered to $42 from $44 at Deutsche Bank
PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

Hot Stocks
Dine Brands appoints Michael Hyter as member of Board of Directors » 17:01
07/14/20
07/14
17:01
07/14/20
17:01
KFY

Korn/Ferry

$28.25 /

+0.305 (+1.09%)

, DIN

Dine Brands

$35.12 /

-0.33 (-0.93%)

The Board of Directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KFY Korn/Ferry
$28.25 /

+0.305 (+1.09%)

DIN Dine Brands
$35.12 /

-0.33 (-0.93%)

KFY Korn/Ferry
$28.25 /

+0.305 (+1.09%)

06/08/20 Sidoti
Korn/Ferry downgraded to Neutral from Buy at Sidoti
05/21/20 Credit Suisse
Korn/Ferry upgraded to Neutral on valuation at Credit Suisse
05/21/20 Credit Suisse
Korn/Ferry upgraded to Neutral from Underperform at Credit Suisse
04/06/20 Goldman Sachs
Goldman cuts staffing estimates, says buy Korn/Ferry, sell Robert Half
DIN Dine Brands
$35.12 /

-0.33 (-0.93%)

04/30/20 MKM Partners
Dine Brands price target raised to $50 from $40 at MKM Partners
04/30/20 Wedbush
Dine Brands price target raised to $60 from $50 at Wedbush
04/20/20 Wedbush
Dine Brands price target lowered to $50 from $110 at Wedbush
02/25/20 MKM Partners
Dine Brands downgraded to Neutral from Buy at MKM Partners
KFY Korn/Ferry
$28.25 /

+0.305 (+1.09%)

DIN Dine Brands
$35.12 /

-0.33 (-0.93%)

KFY Korn/Ferry
$28.25 /

+0.305 (+1.09%)

DIN Dine Brands
$35.12 /

-0.33 (-0.93%)

DIN Dine Brands
$35.12 /

-0.33 (-0.93%)

Hot Stocks
Alamos Gold announces Phase III expansion of Island Gold to 2,000 tpd » 17:01
07/14/20
07/14
17:01
07/14/20
17:01
AGI

Alamos Gold

$10.39 /

+0.555 (+5.64%)

Alamos Gold reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGI Alamos Gold
$10.39 /

+0.555 (+5.64%)

AGI Alamos Gold
$10.39 /

+0.555 (+5.64%)

05/01/20 TD Securities
Alamos Gold price target raised to C$17 from C$16.50 at TD Securities
05/01/20 BMO Capital
BMO backs Outperform on Alamos Gold after Q1 results
04/23/20 National Bank
Alamos Gold upgraded to Outperform from Sector Perform at National Bank
03/12/20 BofA
Alamos Gold downgraded to Underperform from Neutral at BofA
AGI Alamos Gold
$10.39 /

+0.555 (+5.64%)

Hot Stocks
Heritage Insurance sees Q2 net catastrophe losses approximately $17.6M » 16:59
07/14/20
07/14
16:59
07/14/20
16:59
HRTG

Heritage Insurance

$12.69 /

+0.005 (+0.04%)

Heritage Insurance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRTG Heritage Insurance
$12.69 /

+0.005 (+0.04%)

HRTG Heritage Insurance
$12.69 /

+0.005 (+0.04%)

04/06/20 Piper Sandler
Heritage Insurance upgraded to Overweight from Neutral at Piper Sandler
01/09/20
Heritage Insurance management to meet with JMP Securities
11/04/19 Keefe Bruyette
Heritage Insurance downgraded to Market Perform on valuation at Keefe Bruyette
11/04/19 Keefe Bruyette
Heritage Insurance downgraded to Underperform from Market Perform at Keefe Bruyette
HRTG Heritage Insurance
$12.69 /

+0.005 (+0.04%)

Hot Stocks
VirnetX falls after getting unfavorable decisions on patent claims » 16:50
07/14/20
07/14
16:50
07/14/20
16:50
VHC

VirnetX

$5.48 /

-0.78 (-12.46%)

Shares are down an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:46
07/14/20
07/14
16:46
07/14/20
16:46
WFC

Wells Fargo

$24.25 /

-1.18 (-4.64%)

, JPM

JPMorgan

$98.22 /

+0.61 (+0.62%)

, C

Citi

$50.13 /

-2.125 (-4.07%)

, DAL

Delta Air Lines

$26.12 /

-0.71 (-2.65%)

, SPOT

Spotify

$262.59 /

+1.475 (+0.56%)

, RIGL

Rigel Pharmaceuticals

$4.13 /

+1.96 (+90.32%)

, EIGI

Endurance

$4.98 /

+1.03 (+26.08%)

, EQ

Equillium

$13.95 /

-13.1 (-48.43%)

, VRCA

Verrica Pharmaceuticals

$8.48 /

-0.32 (-3.64%)

Stocks spent much of the…

Open Full Text

ShowHide Related Items >><<
WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

C Citi
$50.13 /

-2.125 (-4.07%)

DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

SPOT Spotify
$262.59 /

+1.475 (+0.56%)

RIGL Rigel Pharmaceuticals
$4.13 /

+1.96 (+90.32%)

EIGI Endurance
$4.98 /

+1.03 (+26.08%)

EQ Equillium
$13.95 /

-13.1 (-48.43%)

VRCA Verrica Pharmaceuticals
$8.48 /

-0.32 (-3.64%)

WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

07/10/20 Baird
Wells Fargo upgraded to Outperform from Neutral at Baird
07/09/20 Wolfe Research
Wells Fargo upgraded to Peer Perform from Underperform at Wolfe Research
07/08/20 JPMorgan
Wells Fargo price target lowered to $29.50 from $32 at JPMorgan
07/08/20 Seaport Global
Wells Fargo initiated with a Neutral at Seaport Global
JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

07/09/20 Wolfe Research
JPMorgan upgraded to Outperform from Peer Perform at Wolfe Research
07/09/20 DA Davidson
JPMorgan upgraded to Buy from Neutral at DA Davidson
07/08/20 Seaport Global
JPMorgan initiated with a Buy at Seaport Global
06/23/20 Wells Fargo
Finicity should help MasterCard with open banking efforts, says Wells Fargo
C Citi
$50.13 /

-2.125 (-4.07%)

07/08/20 Seaport Global
Citi initiated with a Buy at Seaport Global
07/07/20 Societe Generale
Societe Generale upgrades BofA, Citi to Buy on 'path to respectability'
07/07/20 Societe Generale
Citi upgraded to Buy from Hold at Societe Generale
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20 Goldman Sachs
Delta Air Lines price target raised to $38 from $33 at Goldman Sachs
06/16/20 Stifel
United loyalty deal raises odds of survival without restructuring, says Stifel
06/10/20 JPMorgan
Delta Air Lines price target lowered to $41 from $45 at JPMorgan
SPOT Spotify
$262.59 /

+1.475 (+0.56%)

10:11 Today
Fly Intel: Top five analyst downgrades
06:24 Today UBS
Spotify double-downgraded to Sell from Buy at UBS
06:13 Today UBS
Spotify downgraded to Sell from Buy at UBS
07/13/20 BofA
Spotify price target raised to $357 from $185 at BofA
RIGL Rigel Pharmaceuticals
$4.13 /

+1.96 (+90.32%)

07/13/20 Cantor Fitzgerald
Cantor says research supports studying Rigel's fostamatinib in treating COVID-19
07/13/20 Citi
Study points to possible role for Rigel in treating COVID injury, says Citi
02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
EIGI Endurance
$4.98 /

+1.03 (+26.08%)

10/15/19 Jefferies
Jefferies selective on Internet into Q3, most positive on Alphabet and Facebook
08/01/19 SunTrust
Endurance turnaround plan looks 'broadly on track,' says SunTrust
EQ Equillium
$13.95 /

-13.1 (-48.43%)

06:24 Today H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
01/03/20 Stifel
Stifel says Incyte setback means Equillium may have most advanced aGVHD product
VRCA Verrica Pharmaceuticals
$8.48 /

-0.32 (-3.64%)

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

C Citi
$50.13 /

-2.125 (-4.07%)

DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

SPOT Spotify
$262.59 /

+1.475 (+0.56%)

RIGL Rigel Pharmaceuticals
$4.13 /

+1.96 (+90.32%)

EIGI Endurance
$4.98 /

+1.03 (+26.08%)

EQ Equillium
$13.95 /

-13.1 (-48.43%)

VRCA Verrica Pharmaceuticals
$8.48 /

-0.32 (-3.64%)

WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

C Citi
$50.13 /

-2.125 (-4.07%)

DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

SPOT Spotify
$262.59 /

+1.475 (+0.56%)

WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

C Citi
$50.13 /

-2.125 (-4.07%)

DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

SPOT Spotify
$262.59 /

+1.475 (+0.56%)

RIGL Rigel Pharmaceuticals
$4.13 /

+1.96 (+90.32%)

EIGI Endurance
$4.98 /

+1.03 (+26.08%)

EQ Equillium
$13.95 /

-13.1 (-48.43%)

VRCA Verrica Pharmaceuticals
$8.48 /

-0.32 (-3.64%)

WFC Wells Fargo
$24.25 /

-1.18 (-4.64%)

JPM JPMorgan
$98.22 /

+0.61 (+0.62%)

C Citi
$50.13 /

-2.125 (-4.07%)

DAL Delta Air Lines
$26.12 /

-0.71 (-2.65%)

SPOT Spotify
$262.59 /

+1.475 (+0.56%)

Hot Stocks
ProQR Therapeutics spikes 14% higher after $30M financing pact with Pontifax » 16:46
07/14/20
07/14
16:46
07/14/20
16:46
PRQR

ProQR Therapeutics

$4.90 /

-0.06 (-1.21%)

shares of ProQR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRQR ProQR Therapeutics
$4.90 /

-0.06 (-1.21%)

PRQR ProQR Therapeutics
$4.90 /

-0.06 (-1.21%)

03/31/20 H.C. Wainwright
H.C. Wainwright cautiously optimistic after ProQR' STELLAR trial interim data
11/06/19 JMP Securities
JMP Securities continues to recommend ProQR Therapeutics after Q3 report
10/10/19 Citi
ProQR Therapeutics price target raised to $40 from $34 at Citi
10/09/19 Cantor Fitzgerald
ProQR shares could more than double on tomorrow's data, says Cantor Fitzgerald
PRQR ProQR Therapeutics
$4.90 /

-0.06 (-1.21%)

  • 17
    Oct
Syndicate
Adaptive Biotechnologies files to sell 8M shares of common stock » 16:45
07/14/20
07/14
16:45
07/14/20
16:45
ADPT

Adaptive Biotechnologies

$43.18 /

-0.98 (-2.22%)

6M of which are being…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

  • 24
    Jan
ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

General News
API crude inventories for week of July 10 » 16:44
07/14/20
07/14
16:44
07/14/20
16:44
USO

United States Oil Fund

$28.88 /

+0.375 (+1.32%)

API reports that crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USO United States Oil Fund
$28.88 /

+0.375 (+1.32%)

USO United States Oil Fund
$28.88 /

+0.375 (+1.32%)

USO United States Oil Fund
$28.88 /

+0.375 (+1.32%)

USO United States Oil Fund
$28.88 /

+0.375 (+1.32%)

Hot Stocks
Capitala Finance reports $95.2M in cash as of June 30 » 16:39
07/14/20
07/14
16:39
07/14/20
16:39
CPTA

Capitala Finance

$2.04 /

-0.175 (-7.90%)

During the second quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPTA Capitala Finance
$2.04 /

-0.175 (-7.90%)

CPTA Capitala Finance
$2.04 /

-0.175 (-7.90%)

05/26/20
Fly Intel: Top five analyst downgrades
05/26/20 JMP Securities
Capitala Finance downgraded to Underperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Capitala downgraded to Underperform from Market Perform at JMP Securities
10/20/19 Keefe Bruyette
Capitala downgraded to Underperform from Market Perform at Keefe Bruyette
CPTA Capitala Finance
$2.04 /

-0.175 (-7.90%)

Hot Stocks
MorphoSys licensee Janssen announces FDA approval of Tremfya » 16:39
07/14/20
07/14
16:39
07/14/20
16:39
MOR

MorphoSys

$31.87 /

-0.68 (-2.09%)

, JNJ

Johnson & Johnson

$147.96 /

+2.66 (+1.83%)

MorphoSys (MOR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOR MorphoSys
$31.87 /

-0.68 (-2.09%)

JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

MOR MorphoSys
$31.87 /

-0.68 (-2.09%)

06/25/20 RBC Capital
MorphoSys downgraded to Sector Perform from Outperform at RBC Capital
05/13/20 Barclays
MorphoSys price target raised to EUR 105 from EUR 100 at Barclays
05/12/20 HSBC
MorphoSys upgraded to Hold from Reduce at HSBC
03/25/20 Oppenheimer
Incyte price target lowered to $85 from $99 at Oppenheimer
JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
MOR MorphoSys
$31.87 /

-0.68 (-2.09%)

JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

MOR MorphoSys
$31.87 /

-0.68 (-2.09%)

JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

MOR MorphoSys
$31.87 /

-0.68 (-2.09%)

JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

JNJ Johnson & Johnson
$147.96 /

+2.66 (+1.83%)

Syndicate
Adaptive Biotechnologies files automatic mixed securities shelf  16:37
07/14/20
07/14
16:37
07/14/20
16:37
ADPT

Adaptive Biotechnologies

$43.23 /

-0.93 (-2.11%)

 
ShowHide Related Items >><<
ADPT Adaptive Biotechnologies
$43.23 /

-0.93 (-2.11%)

ADPT Adaptive Biotechnologies
$43.23 /

-0.93 (-2.11%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ADPT Adaptive Biotechnologies
$43.23 /

-0.93 (-2.11%)

  • 24
    Jan
ADPT Adaptive Biotechnologies
$43.23 /

-0.93 (-2.11%)

Hot Stocks
TriMas appoints Fabio Salik as President of Rieke, effective July 15 » 16:36
07/14/20
07/14
16:36
07/14/20
16:36
TRS

TriMas

$24.24 /

+0.7 (+2.97%)

TriMas announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRS TriMas
$24.24 /

+0.7 (+2.97%)

TRS TriMas
$24.24 /

+0.7 (+2.97%)

04/02/20 William Blair
TriMas upgraded to Outperform from Market Perform at William Blair
01/07/20 KeyBanc
NN, Inc. could 'benefit the most' from strategic divestiture, says KeyBanc
TRS TriMas
$24.24 /

+0.7 (+2.97%)

Hot Stocks
VirnetX says it will consider all options on PTAB 'unpatentable' decisions » 16:34
07/14/20
07/14
16:34
07/14/20
16:34
VHC

VirnetX

$5.48 /

-0.78 (-12.46%)

Virnet X Holding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

VHC VirnetX
$5.48 /

-0.78 (-12.46%)

Hot Stocks
Genuine Parts' Sonnemaker resigns to pursue other opportunities » 16:34
07/14/20
07/14
16:34
07/14/20
16:34
GPC

Genuine Parts

$86.18 /

+1.045 (+1.23%)

Genuine Parts Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPC Genuine Parts
$86.18 /

+1.045 (+1.23%)

GPC Genuine Parts
$86.18 /

+1.045 (+1.23%)

04/08/20
Fly Intel: Top five analyst upgrades
04/08/20 BofA
Genuine Parts upgraded to Buy from Neutral at BofA
04/08/20 BofA
Genuine Parts upgraded to Buy from Neutral at BofA
04/01/20 Stephens
Genuine Parts downgraded to Equal Weight from Overweight at Stephens
GPC Genuine Parts
$86.18 /

+1.045 (+1.23%)

Conference/Events
Morgan Stanley natural gas analysts hold an analyst/industry conference call » 16:32
07/14/20
07/14
16:32
07/14/20
16:32
MCO

Moody's

$291.35 /

+5.49 (+1.92%)

Global Natural Gas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCO Moody's
$291.35 /

+5.49 (+1.92%)

MCO Moody's
$291.35 /

+5.49 (+1.92%)

07/08/20 Goldman Sachs
Moody's price target raised to $295 from $258 at Goldman Sachs
06/08/20 BMO Capital
Moody's price target raised to $298 from $285 at BMO Capital
05/29/20 Credit Suisse
Moody's initiated with an Outperform at Credit Suisse
05/18/20 Oppenheimer
Moody's initiated with an Outperform at Oppenheimer
MCO Moody's
$291.35 /

+5.49 (+1.92%)

MCO Moody's
$291.35 /

+5.49 (+1.92%)

Options
Preliminary option volume of 25.8M today » 16:30
07/14/20
07/14
16:30
07/14/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
CubicFarm Systems initiated with a Strong Buy at Raymond James » 16:29
07/14/20
07/14
16:29
07/14/20
16:29
CUBXF

CubicFarm Systems

$0.00 /

+ (+0.00%)

Raymond James initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Seagate initiated with a Market Perform at Bernstein » 16:28
07/14/20
07/14
16:28
07/14/20
16:28
STX

Seagate

$47.38 /

+0.04 (+0.08%)

, WDC

Western Digital

$42.05 /

+0.2 (+0.48%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

16:27 Today Bernstein
Western Digital initiated with an Outperform at Bernstein
06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
06/08/20 Rosenblatt
Rosenblatt starts Western Digital at Neutral, sees technology lagging Seagate
06/08/20 Rosenblatt
Rosenblatt starts Seagate at Buy, sees technology lead over Western Digital
WDC Western Digital
$42.05 /

+0.2 (+0.48%)

16:27 Today Bernstein
Western Digital initiated with an Outperform at Bernstein
16:10 Today Bernstein
Western Digital initiated with an Outperform at Bernstein
06/30/20 Benchmark
Micron report and guidance 'bode well' for Western Digital, says Benchmark
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

Initiation
Western Digital initiated with an Outperform at Bernstein » 16:27
07/14/20
07/14
16:27
07/14/20
16:27
WDC

Western Digital

$42.05 /

+0.2 (+0.48%)

, STX

Seagate

$47.38 /

+0.04 (+0.08%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

16:10 Today Bernstein
Western Digital initiated with an Outperform at Bernstein
06/30/20 Benchmark
Micron report and guidance 'bode well' for Western Digital, says Benchmark
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/22/20 Benchmark
Western Digital upgraded to Buy from Hold at Benchmark
STX Seagate
$47.38 /

+0.04 (+0.08%)

06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
06/08/20 Rosenblatt
Rosenblatt starts Western Digital at Neutral, sees technology lagging Seagate
06/08/20 Rosenblatt
Rosenblatt starts Seagate at Buy, sees technology lead over Western Digital
06/08/20 Rosenblatt
Seagate initiated with a Buy at Rosenblatt
WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

WDC Western Digital
$42.05 /

+0.2 (+0.48%)

STX Seagate
$47.38 /

+0.04 (+0.08%)

Downgrade
Waste Management downgraded to Neutral from Outperformer at CIBC » 16:23
07/14/20
07/14
16:23
07/14/20
16:23
WM

Waste Management

$106.18 /

+1.85 (+1.77%)

CIBC downgraded Waste…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WM Waste Management
$106.18 /

+1.85 (+1.77%)

WM Waste Management
$106.18 /

+1.85 (+1.77%)

07/01/20 Jefferies
GFL Environmental initiated with a Buy at Jefferies
06/24/20 Stifel
Waste Management proves discipline in paying less for Advanced, says Stifel
06/24/20 BMO Capital
BMO keeps Outperform on Waste Management after amended deal terms
06/19/20 Jefferies
Jefferies doesn't see Waste Connections as buyer of Advanced Disposal assets
WM Waste Management
$106.18 /

+1.85 (+1.77%)

WM Waste Management
$106.18 /

+1.85 (+1.77%)

WM Waste Management
$106.18 /

+1.85 (+1.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.